THE GRAND VISION
What we eat
determines us
THE GRAND VISION
What we eat
determines us
"Our lab operates at the critical intersection of genetics, microbiology, and nutrition."
"We decode the complex dialogue between our genes and the trillions of microbes in our gut to understand how diet impacts health and disease."
"Our mission is to translate this fundamental knowledge into targeted nutritional and pharmacological strategies."
Traditional pharmacology often overlooks the vast influence of the gut microbiome. Our lab's multi-omics platform integrates transcriptomics, metabolomics, and metagenomics to build a complete picture. This allows us to identify how phytochemicals truly work in the body, paving the way for next-generation precision therapeutics.
Ko et al. Identification of components from Aralia elata and their effects on muscle health and gut microbiota. J. Funct. Foods. 2024
Nguyen et al. Cornflower Extract and Its Active Components Alleviate Dexamethasone-Induced Muscle Wasting by Targeting Cannabinoid Receptors and Modulating Gut Microbiota. Nutrients. 2024
Nam and Kim et al. Sanguisorba officinalis L. ameliorates hepatic steatosis and fibrosis by modulating oxidative stress, fatty acid oxidation, and gut microbiota in CDAHFD-induced mice. Nutrients. 2023
Why does a drug work for one person but not another? The answer often lies in our unique genetic blueprint. Our research utilizes advanced models, including genetically diverse Diversity Outbred mice, to simulate human genetic variation. This powerful approach allows us to unravel how diet and medications interact with host genetics, with the ultimate goal of designing rational interventions to combat geriatric diseases like sarcopenia, NASH, and cancer cachexia.
Hong et al. Host-specific effects of Eubacterium species on Rg3-mediated modulation of osteosarcopenia in a genetically diverse mouse population. Microbiome. 2024
Nguyen et al. Dexamethasone-induced muscle atrophy and bone loss in six genetically diverse collaborative cross founder strains demonstrate phenotypic variability by Rg3 treatment. J. Ginseng Res. 2024
Kim et al. Integrative analysis of hepatic transcriptional profiles reveals genetic regulation of atherosclerosis in hyperlipidemic Diversity Outbred-F1 mice. Sci. Rep. 2023
Kim et al. Hepatic transcriptional profile reveals the role of diet and genetic backgrounds on metabolic traits in female progenitor strains of the Collaborative Cross. Physiol. Genomics. 2021